The design and functional characterization of the antimicrobial and antibiofilm activities of BMAP27-Melittin, a rationally designed hybrid peptide

International Journal of Peptide Research and Therapeutics

Volumn 21, Issue 2, 2015, Pages 165-177

  Almaaytah, Ammar ^a   Tarazi, Shadi ^a   Al Fandi, Mohammad ^a   Abuilhaija, Ahmad ^a   Al Shar'i, Nizar ^a   Al Balas, Qosay ^a   Abu Awad, Aymen ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b KING HUSSEIN MEDICAL CENTER   (Jordan)

Author keywords

Antibiofilm; Antimicrobial peptides; BMAP 27; Folding simulations; Hybrid peptide; Melittin

Indexed keywords

EID: 84939978885     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-014-9444-6     Document Type: Article

References (39)

1. Almaaytah A, Zhou M, Wang L, Chen T, Walker B, Shaw C (2012) Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. Peptides 35:291-299
2. Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG (1992) Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity. FEBS Lett 296(2):190-194
3. Asthana N, Yadav SP, Ghosh JK (2004) Dissection of antibacterial and toxic activity of melittin: a leucine zipper motif plays a crucial role in determining its hemolytic activity but not antibacterial activity. J Biol Chem 279:55042-55050
4. Berendsen HJC, Postma JPM, Gunsteren WFV, DiNola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684-3690
5. Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K et al (2002) The protein data bank. Acta Crystallogr Sect D 58:899-907
6. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Micro 3:238-250
7. Brooks BR, Brooks CL, Mackerell AD, Nilsson L, Petrella RJ, Roux B et al (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30:1545-1614
8. Carlet J, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D et al (2012) Ready for a world without antibiotics? The pensieres antibiotic resistance call to action. Antimicrob Resist Infect Control 1:11
9. Carlet J, Pulcini C, Piddock LJV (2014) Antibiotic resistance: a geo-political issue. Clin Microbiol Infect. doi: 10.1111/1469-0691.12767
10. Ceri H, Olson M, Morck D, Storey D, Read R, Buret A et al (2001) The MBEC assay system: multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol 337:377-385
11. Discovery Studio (2013) version 3.5 ed. Accelrys Inc., San Diego
12. Dominy BN, Brooks CL (1999) Development of a generalized born model parametrization for proteins and nucleic acids. J Phys Chem B 103:3765-3773
13. Eckert R, Qi F, Yarbrough DK, He J, Anderson MH, Shi W (2006) Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. Antimicrob Agents Chemother 50:1480-1488
14. Eisenberg D, Terwilliger TC, Tsui F (1980) Structural studies of bee melittin. Biophys J 32(1):252-254
15. Feng X, Sambanthamoorthy K, Palys T, Paranavitana C (2013) The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii. Peptides 49:131-137
16. Fjell CD, Hiss JA, Hancock REW, Schneider G (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11:37-51
17. Fox JL (2013) Antimicrobial peptides stage a comeback. Nat Biotechnol 31(5):379-382
18. Freire-Moran L, Aronsson B, Manz C, Gyssens IC, So AD, Monnet DL et al (2011) Critical shortage of new antibiotics in development against multidrug-resistant bacteria - Time to react is now. Drug Resist Updat 14:118-124
19. Giacometti A, Cirioni O, Kamysz W, D'Amato G, Silvestri C, Del Prete MS et al (2003) Comparative activities of cecropin A, melittin, and cecropin A - melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. Peptides 24:1315-1318
20. Giuliani A, Pirri G, Nicoletto S (2007) Antimicrobial peptides: an overview of a promising class of therapeutics. Central Eur J Biol 2:1-33
21. Hoiby N, Ciofu O, Johansen HK, Z-J Song, Moser C, Jensen PO et al (2011) The clinical impact of bacterial biofilms. Int J Oral Sci 3:55-65
22. Huang Y, Huang J, Chen Y (2010) Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein Cell 1:143-152
23. Huang Y, He L, Li G, Zhai N, Jiang H, Chen Y (2014) Role of helicity of α-helical antimicrobial peptides to improve specificity. Protein Cell 5:631-642
24. Jenssen H, Hamill P, Hancock REW (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19:491-511
25. Marr AK, Gooderham WJ, Hancock REW (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6:468-472
26. Mascio CTM, Alder JD, Silverman JA (2007) Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob Agents Chemother 51:4255-4260
27. Olson ME, Ceri H, Morck DW, Buret AG, Read RR (2002) Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res 66:86-92
28. Ouhara K, Komatsuzawa H, Kawai T, Nishi H, Fujiwara T, Fujiue Y et al (2008) Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. J Antimicrob Chemother 61:1266-1269
29. Park Y, Lee DG, Hahm KS (2004) HP(2-9)-magainin 2(1-12), a synthetic hybrid peptide, exerts its antifungal effect on Candida albicans by damaging the plasma membrane. J Pept Sci 10(4):204-209
30. Pasupuleti M, Schmidtchen A, Malmsten M (2012) Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol 32:143-171
31. Peters BM, Shirtliff ME, Jabra-Rizk MA (2010) Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog 6:e1001067
32. Pompilio A, Scocchi M, Pomponio S, Guida F, Di Primio A, Fiscarelli E et al (2011) Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. Peptides 32:1807-1814
33. Ryckaert J-P, Ciccotti G, Berendsen HJC (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23:327-341
34. Saravolatz LD, Pawlak J, Johnson L, Bonilla H, Fakih MG, Fugelli A et al (2012) In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus. Antimicrob Agents Chemother 56:4478-4482
35. Shin SY, Kang JH, Lee MK, Kim SY, Kim Y, Hahm KS (1998) Cecropin A-magainin 2 hybrid peptides having potent antimicrobial activity with low hemolytic effect. Biochem Mol Biol Int 44(6):1119-1126
36. Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M (1996) Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem 271:28375-28381
37. Vogel H, Jaehnig F (1986) The structure of melittin in membranes. Biophys J 50(4):573
38. Wang W, Tao R, Tong Z, Ding Y, Kuang R, Zhai S et al (2012) Effect of a novel antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans biofilms. Peptides 33:212-219
39. Wiesner J, Vilcinskas A (2010) Antimicrobial peptides: the ancient arm of the human immune system. Virulence 1:440-464